相关实验视频

Updated: Jun 3, 2025

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

一种新的同位素光纤:蓝光对抗药物耐药生物的抗菌作用

Megan H Goh¹, Robert A Rabiner², Joseph J Connolly¹

¹Department of Orthopaedic Surgery, Division of Orthopaedic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society

|January 8, 2025

概括

使用一种新型光纤的抗微生物蓝光疗法有效地杀死了耐美西林的金黄色葡萄球菌 (MRSA) 和耐多药的空气菌 (Pseudomonas aeruginosa). 这种创新方法对治疗耐药生物体 (DROs) 显示出希望.

科学领域:

照相医疗 (photomedicine) 是一种医学.
抗微生物疗法中的抗微生物疗法
细菌学细菌学是一门学科.

背景情况:

耐药生物体 (DROs) 构成了重大的全球健康挑战,推动了对新型治疗策略的需求.
抗微生物蓝光 (ABL) 治疗是一种有前途的方法,利用光刺激产生活性氧物种,导致细菌细胞死亡.

研究的目的:

评估一种新型同位素光纤在体外的疗效,该光纤可提供ABL,用于对抗多药耐药的阴性细菌Pseudomonas aeruginosa (MDR-Pa) 和抗甲素耐药的金黄色葡萄球菌 (MRSA).

主要方法:

用MDR-Pa和MRSA培养物通过新型同位素光纤暴露于ABL进行了杀死时间测试.
实验使用了五个波长 (405-475纳米) 在低功率 (LP) 和高功率 (HP) 配置下交付.
杀菌性减少被定义为每毫升殖民地形成单位 (CFU/mL) 的≥3 log10减少.

主要成果:

在LP-ABL和HP-ABL条件下,光纤显示出对MRSA的显著杀菌作用.
针对MDR-Pa的显著杀菌作用仅在HP-ABL条件下观察到.
具体的log10 CFU/mL减量和p值为每个条件和时间点详细说明.

结论:

这种新型的同位光纤在体外有效地根除了MRSA和MDR-Pa,证实了其杀菌能力.
这项技术显示出作为对抗耐药生物体的可行治疗选择的潜力.

关键词:

在MRSA中,MRSA可能是MRSA.伪omonas空气菌伪omonas空气菌抗微生物耐药性抗微生物耐药性蓝光是蓝色的光,它是蓝色的.药物耐药的生物体.

更多相关视频

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate

Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate

Published on: April 6, 2022

相关概念视频

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...